Venmax Drugs and Pharmaceuticals Ltd — Results, 23-07-2025: Result

Venmax Drugs & Pharmaceuticals announced its Q1 FY26 financial results. The company reported revenue from operations of ₹1.21 Cr, a significant increase compared to ₹0.10 Cr in the same quarter last year. Profit for the period stood at ₹0.0374 Cr, up from ₹0.0108 Cr year-on-year. This growth indicates improved operational performance. The financial results for the quarter were reviewed by the Audit Committee and approved by the Board. The statutory auditors provided an unmodified conclusion on the unaudited standalone results. The company continues to operate in a single segment.